Research Education: Initiative for Maximizing Student Development (IMSD) Program (R25)

The summary for the Research Education: Initiative for Maximizing Student Development (IMSD) Program (R25) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Research Education: Initiative for Maximizing Student Development (IMSD) Program (R25): The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIGMS R25 program is to support educational activities that enhance the diversity of the biomedical workforce.

Federal Grant Title:	Research Education: Initiative for Maximizing Student Development (IMSD) Program (R25)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-17-053
Type of Funding:	Grant
CFDA Numbers:	93.859
CFDA Descriptions:	Information not provided
Current Application Deadline:	January 28th, 2019
Original Application Deadline:	January 28th, 2019
Posted Date:	November 10th, 2016
Creation Date:	November 10th, 2016
Archive Date:	February 28th, 2019
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	November 10th, 2016

Applicants Eligible for this Grant: Public and State controlled institutions of higher education - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) ; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. See FOA for eligibility details
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/PAR-17-053.html
Grant Announcement Contact: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • The NIGMS Human Genetic Cell Repository (U42 - Clinical Trial Not Allowed); • Limited Competition: NIGMS Mature Synchrotron Resources for Structural Biology (P30 - Clin...; • Maximizing Access to Research Careers (T34); • Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34); • Limited Competition: NIGMS Legacy Community-Wide Scientific Resources (R24 Clinical Trial ...; • Tools for Genetic and Genomic Studies in Emerging Model Organisms; • Evolution of Infectious Diseases; • Mbrs Support of Continuous Research Excellence (Score)
More Grants from the National Institutes of Health: • Sponsored Programs Administration Development (SPAD) Program (UC2 - Clinical Trial Not All...; • PrEP for HIV Prevention among Substance Using Populations (R01 Clinical Trial Optional); • Rapid Assessment of Drug Abuse: Smart City Tools (R43/R44 - Clinical Trial Optional); • Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Tr...; • Rapid Assessment of Drug Abuse: Smart City Tools (R41/R42 - Clinical Trial Optional)